Page results
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
Out-patient IV antibiotic service
-
Find and Treat screen tens of thousands of the most vulnerable, homeless and high-risk people every year using mobile units deployed from UCLH.
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma